LEXICON PHARMACEUTICALS, INC. Business Operations Contracts & Agreements
13 Contracts & Agreements
- Agency Agreements (1 contract)
- Collaboration Agreements (8)
- Development Agreements (1)
- Supply Agreements (2)
- Termination Agreements (1)
- Placement Agency Agreement (Filed With SEC on December 11, 2020)
- Confidential Termination and Settlement Agreement and Mutual Releases, dated September 9, 2019, with Sanofi-Aventis Deutschland GmbH (Filed With SEC on November 7, 2019)
- Amendment One to Commercial Supply Agreement (Filed With SEC on March 15, 2019)
- Amendment Two to Commercial Supply Agreement (Filed With SEC on March 15, 2019)
- Amendment No. 1 to Collaboration and License Agreement, dated July 1, 2017, with Sanofi-Aventis Deutschland GmbH (Filed With SEC on November 8, 2017)
- SECOND AMENDMENT TO COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on November 7, 2016)
- FIRST AMENDMENT TO LICENSE AND COLLABORATION AGREEMENT (Filed With SEC on May 5, 2015)
- COLLABORATION AND LICENSE AGREEMENT between LEXICON GENETICS INCORPORATED and BRISTOL-MYERS SQUIBB COMPANY Collaboration and License Agreement (Filed With SEC on May 5, 2015)
- First Amendment to Collaboration and License Agreement (Filed With SEC on May 5, 2015)
- LICENSE AND COLLABORATION AGREEMENT By and Between IPSEN PHARMA SAS and LEXICON PHARMACEUTICALS, INC (Filed With SEC on November 6, 2014)
- Collaboration and License Agreement (Filed With SEC on May 10, 2010)
- Amended and Restated Research and Development Agreement (Filed With SEC on August 8, 2007)
- First Amendment to Collaboration and License Agreement (Filed With SEC on August 4, 2006)
